Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
panTB-HM: Sutezolid Regimens for Tuberculosis
NCT05686356Phase 3Active, not recruiting
- Sponsor
- Aurum Institute
- Start
- Jul 2023
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of sutezolid in pulmonary tuberculosis (TB), sponsored by Aurum Institute. Started Jul 2023; status: active, not recruiting.
02
Drugs
sutezolid
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT05686356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05686356.